Strong 42% growth masked by flat profitability and doubling debt
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Revenue growth claim (42% vs 42.1% delivered) met. PAT claim (863 lakhs, −3 paisa) matched. Margin improvement claim overstated; EBITDA per kilo price-linked, not structural. CNSL/solar timelines already slipping.
Neutral
next 1–2 quarters
Optimistic
multi-year
Q2 delivers 42% revenue growth but profit stagnates (−0.7% PAT); debt nearly doubled to 232 Cr amid extended supply-chain cycles and rising raw-material costs. Management's expansion plan (1,000 MT by FY37, CNSL/solar by December) is ambitious but already delayed and offers no near-term margin relief. Profitability remains hostage to raw-cashew-price dynamics, not operational leverage. Risk-reward neutral.
₹246.7 Cr
Revenue · +42.1% YoY₹8.6 Cr
Reported PAT · −0.7% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Revenue 246 crores, 42% YoY growth
METDelivered 246.7 Cr revenue, +42.1% YoY confirmed
PAT at 863 lakhs, marginally 3 paisa lower YoY
METDelivered 8.6 Cr (860 lakhs), -0.7% YoY matches call's claim
EBITDA margins improved compared to last year
OVERSTATEDEBITDA 23 Cr on 246 Cr = 9.3% margin; claim relies on absolute rupees not %; per-kilo EBITDA ~7 rupees, price-dependent
Finance cost has not increased significantly
MISSFinance cost rose 8.36 Cr (H2 FY26) to 8.39 Cr (H1 FY27); borrowing doubled 111→232 Cr; downplaying scale of debt
CNSL oil, solar plants final stages, mid/end December completion
MISSAlready 2–3 months delayed; timelines uncertain; management candid about execution risks with larger shareholders
Deeper value-chain integration will increase margin and reduce finance costs
OVERSTATEDDeeper buying increased WC by 150–200 days; finance costs rose; absolute EBITDA per kilo flat despite higher prices; benefit not yet visible
Earnings quality
What changed since the last call
Borrowing structure
DowngradeDebt 111 Cr (H2 FY26) → 232 Cr (H1 FY27). Management frames as WC-driven, but scale is material; finance cost 8.39 Cr vs 8.36 Cr eroding PAT.
Transit timelines
DowngradeSourcing shift to direct African import extended transit 35–45 days → 110–112 days. Increases inventory, WC, and cost at scale.
Capex intensity
DowngradeNew 114 Cr capex approved; 30-month timeline (Nov 2026 → Sept 2029). Already 2–3 months behind on CNSL/solar; execution risk high.
Forward guidance transparency
DowngradePrior call: 'strong growth rates similar to FY26 into FY27, scaling operations, value-added products.' This call: zero quantified FY27–28 revenue/PAT guidance; cites management lesson on internal timelines.
The Q&A
Analyst Aryan pressed hard on why deeper value-chain integration has not improved margins despite increased WC burden; management deflected to price dynamics and percentage-vs-absolute-terms framing. Masood Shaikh asked about next-year profit doubling; management refused forward guidance. Tone: defensive, evasive on profitability mechanics.
Sourcing & logistics — Karan Singh
AnsweredDirect from African origins; shipments transit 100+ days now (vs 35–45 prior). Red Sea disruptions, Bab el-Mandeb closures extended logistic cycles.
Borrowing & finance cost — Karan Singh
PartialBorrowing driven by (1) raw-material price rise (150→200 rupees/kilo), (2) extended transit (110–112 vs 35–45 days), (3) Diwali inventory build. Finance cost not increased significantly on a like-to-like basis; terminal numbers are balance-sheet snapshots.
CNSL & solar capex — Karan Singh
PartialFinal stages; expecting completion mid/end December, subject to approvals. Definitely will give positive impact on H2.
Export margin profile — Karan Singh
AnsweredExport does not give great margins. India is better price-payer; international market more liquid but margin profile similar. Let cashew price fall by 50%; will see double-digit H2. If rise by 50%, not something the way it works.
Margin improvement & WC — Aryan
DodgedFinance cost not increased like-to-like. Deeper buying (origin-side) has three benefits: (1) better procurement control, (2) additional margin addition, (3) logistics efficiency. This year logistic time expanded (exceptional, Red Sea). Cannot compare with peers; each has different strategy.
Sustainable margins & capex path — Aryan
PartialWhen percentage asked, already explained how things work. EBITDA per tonnage on kilo basis, not percentage. Margin per kg remains stable; denominator (price) increases. Longer term, clear we want to go deeper into value chain; learned from management that internal timelines are non-negotiable for large shareholders.
Capacity utilization & expansion pace — Aryan
AnsweredYes, 95–97% utilization. 1,000 MT target (additional 800 MT) is 10 years out; very much achievable. Timelines difficult to predict; depends on enablers. Conservative on capacity; did not want 240–250-ton scale at IPO. Will expand as utilization reaches comfortable drop level.
Working capital & debt financing — Aryan
PartialPositive cash flow happens if investing > cash flow (invest and grow). Want to invest and grow or want positive cash flow. Debt linked to WC (working capital), which is price-driven. Long-term debt lowest in company. Will borrow long-term if prices go higher.
Capex funding & net debt trajectory — Aryan
PartialPositive cash flow, yes, is a thing if investing more then cash flow not positive. If not investing, cash flow positive. Want to invest/grow or positive cash flow. From debt perspective, WC debt will go up further if prices go up further. From long-term debt, lowest. Debt you are looking at is WC debt.
Realization & pricing dynamics — Deeya Jain
AnsweredKernel realization average 735–738 per unit. Depends on (1) raw cashew nuts, (2) shell prices, (3) processing cost & packing material cost. Shells & packing linked to crude-oil prices (biofuel, bio-coal). No significant change expected for 6 months unless world scenarios shift (e.g., El Niño).
Capex land & scaling constraints — Karan Singh
AnsweredAfter capex, from existing unit & new unit, cannot expand without complete new expansion. Entire new unit from sizing, cooking to grading. If want more, need more land.
CNSL plant & margins — Shiv Muttoo
AnsweredUtilization by end of year should be at full input levels. Plant designed for 150 tons/day (150 MT shells → lab plant 150 MT capacity). Margins higher on cashew shells (18–20 rupees currently) vs raw cashew (200 rupees/kilo); shells at range 18–20 rupees, but comparing 200 vs 20 rupees is 10% margin (2 rupees per 20 rupee = 10%).
Forward guidance & profit growth — Masood Shaikh
DodgedProfit increases via capacity enhancement & deeper value-chain benefits. Cannot give future-looking statements. Can give a number, but let internal accruals fund it; will see.
Africa direct sourcing vs merchant traders — Aryan
AnsweredAfrica farm direct buy not possible; countries have auction systems & licensing. Port-based buying requires cost structures & legal entities. Current scale/size, not advantageous. Better to have knowledge of port-based pricing & buy from port-based sellers.
Capex & revenue contribution post-FY29 — Raghav
PartialWill be proportionate basis. Already at 140 tons. Done on very proportionate basis. Everything is a math; you can get that number.
Guidance
No quantified FY27–28 revenue guidance provided
LowCall declined forward-looking statements. Prior call cited 'strong growth similar to FY26' but no number. This call reaffirmed 42% growth is real but no next-year anchor.
No explicit margin guidance; EBITDA per kilo ~7 rupees, price-driven
LowManagement frames margins as hostage to raw-cashew prices (150→200 rupee swings). No sustainable margin improvement guidance; deflects to price dynamics.
114 Cr expansion capex over 30 months; 200 MT target by FY29
MediumExpansion approved Nov 2026; 30-month timeline (→Sept 2029). CNSL/solar already 2–3 months late; execution risk high. Internal accruals + debt to fund.
Risks the call surfaced
Commodity price exposure
HighEBITDA per kilo stable ~7 rupees; margin % inversely linked to raw-material cost. Management explicit: 50% cashew price rise → margin compression; 50% fall → margin expansion. No pricing power.
Working-capital intensity
HighTransit time extended 35–45 days → 110–112 days (Red Sea disruptions). WC cycle 150–200 days. Requires 232 Cr borrowing; finance costs 8.39 Cr eroding PAT.
Capex execution risk
High114 Cr capex approved Nov 2026; 30-month timeline → Sept 2029. CNSL oil & solar plants already 2–3 months delayed (promised Oct 31, now mid/end Dec). Larger shareholder feedback cited on non-negotiable timelines.
Leverage & debt service
HighDebt 232 Cr (109% YoY growth) on PAT 8.6 Cr; debt-to-EBITDA ~10x (232/23). No positive free cash flow; growth funded by debt. If EBITDA or realization declines, debt-service burden becomes unsustainable.
Margin dilution despite scale
Medium42% revenue growth with −0.7% PAT growth. Deep value-chain integration (origin-direct sourcing, CNSL, adjacent segments) promised margin benefits, but WC inflation & finance costs are offsetting EBITDA gains. Risk: further scale without margin improvement.
Management
Score 5/10. Evasive on forward guidance ('cannot give future-looking statements'). Relied heavily on price-dynamics framing rather than operational transparency. Candid on delays (CNSL/solar 2–3 months behind) but minimized impact. Revenue growth real (42% YoY). Capex approved & in progress; CNSL/solar already delayed. Prior guidance ('strong growth, value-chain expansion') partially delivered (growth yes, profitability no). Track record mixed.
1 · Dec 2026 (mid/end)
CNSL oil plant & solar commissioning; promised positive H2 impact
2 · FY29 (~Sept 2028)
Capex expansion to 200 MT (60 MT additional); organic growth resumes post-capex
3 · Q3–Q4 FY27
Margin recovery if raw-cashew prices fall OR realization uplift from CNSL/food-fuel-feed segments
Risk-reward neutral.
42% Revenue Growth Derailed by Debt Burden and Margin Stagnation
Strong revenue growth masks flat profitability as debt burden and extended supply chains erode operational leverage. Management's value-chain integration strategy has inflated working capital without delivering promised margin relief.
₹246.7 Cr
+42.1% YoY
₹8.6 Cr
−0.7% YoY (flat)
₹232 Cr
+109% YoY (doubled)
₹8.39 Cr
(97% of PAT)
On the headline, Aelea Commodities delivered impressive revenue growth: ₹246.7 crore, up 42% year-on-year. But the profit line tells a different story. Net profit of ₹8.6 crore was essentially flat — down 0.7% — despite the revenue surge. Debt nearly doubled to ₹232 crore, and finance costs of ₹8.39 crore now consume 97% of the company's bottom line. The story of this quarter is not growth, but leverage: strong top-line momentum masked by structural headwinds that management's strategy has yet to solve.
Claims vs. What Holds Up
Revenue ₹246 Cr, 42% YoY growth
Delivered ₹246.7 Cr, +42.1% YoY
Supported
PAT ₹863 lakhs, −0.7% YoY
Delivered ₹8.6 Cr (860 lakhs), −0.7% YoY
Supported (but masked by debt)
EBITDA margins improved vs last year
EBITDA ₹23 Cr on ₹246 Cr = 9.3%; per-kilo EBITDA ~₹7, price-linked not structural
Overstated
Finance cost not increased significantly
Debt doubled ₹111 → ₹232 Cr; cost rose ₹8.36 → ₹8.39 Cr; downplaying leverage scale
Contradicted
Deep value-chain integration will increase margin and reduce finance cost
WC extended 150–200 days, debt up ₹121 Cr, margin unchanged despite higher prices
Overstated
CNSL oil & solar completion mid/end December
Already 2–3 months delayed from Oct 31 target; timelines uncertain
Delayed
Where the Profit Comes From
EBITDA of ₹23 crore (9.3% margin) is being consumed by two forces. First, finance costs of ₹8.39 crore — driven by ₹232 crore in debt, itself inflated by an extended working capital cycle (now 150–200 days vs. the prior normal). Management frames this as temporary (commodity prices, Red Sea disruptions), but the reality is structural: direct African origin sourcing and deeper value-chain integration require longer transit (110–112 days) and higher inventory, locking in debt-service drag. Second, the per-kilo EBITDA of approximately ₹7 is held constant across a 150–200 rupee raw cashew price range — meaning margins compress as absolute prices rise (denominator effect) and expand only if raw cashew prices fall. There is no operational leverage, and there is no pricing power.
What Changed on This Call
Borrowing structure: Debt ₹111 Cr (H2 FY26) → ₹232 Cr (H1 FY27). Management frames as working-capital-driven, but the scale (₹121 Cr increase, +109%) is material.
Supply chain extension: Sourcing shift to direct African import extended transit 35–45 days → 110–112 days. Increases inventory, working capital, and borrowing at scale.
Capex intensity: New ₹114 Cr capex approved; 30-month timeline (Nov 2026 → Sept 2029). Already 2–3 months behind on CNSL/solar; execution risk high.
Forward guidance transparency: Prior call: 'strong growth rates similar to FY26 into FY27.' This call: zero quantified FY27–28 revenue/PAT guidance.
Management tone: Analyst Aryan pressed hard on why deep value-chain integration has not improved margins; management deflected to price dynamics. Tone defensive, evasive.
The Market's View
The stock sits at ₹108.8 as of 6 November — down 68% from its all-time high of ₹344, oversold (RSI 26.8), and below all major moving averages (SMA20 ₹132.86, SMA50 ₹143.25, SMA200 ₹142.26). The 52-week range is ₹102.2–₹196; the stock trades near the midpoint but remains deeply underwater vs. its historical peak. Volume is trending up, suggesting some institutional interest despite weak price. Ownership is heavily promoter-concentrated (63.74%), with minimal FII exposure (0.07%) and zero DII interest. The market's skepticism is evident in the valuation: the 68% drawdown reflects not just this quarter's flat profit, but accumulated doubt about whether capex will convert debt into growth.
Risks, Ranked by Severity to a Holder
Debt-to-EBITDA ~10x; leverage erodes all upside
HIGHDebt ₹232 Cr, EBITDA ₹23 Cr. Limited headroom if realization or EBITDA declines. Every ₹1 Cr loss in EBITDA costs ₹8.39 Cr in finance cost (unchanged), eroding PAT by ₹9.39 Cr (vs current ₹8.6 Cr).
Raw cashew commodity price linkage; no pricing power
HIGHEBITDA per kilo ~₹7 across ₹150–200 raw cashew price range. 50% price swing = ±50% impact on PAT. Management explicit: margins hostage to commodity, not operational excellence.
Working capital cycle (150–200 days) + supply chain disruption
HIGHTransit ₹110–112 days (vs 35–45 prior), inventory up, WC cycle extended. Requires ₹232 Cr in borrowing; further disruptions extend cycle further, raising finance costs.
Capex execution delays; 30-month timeline at risk
HIGHCNSL/solar already 2–3 months behind. 60 MT expansion (140→200 MT) timeline is critical for organic growth post-FY28; slippage jeopardizes FY29 comps and compounds debt burden.
Margin dilution despite scale; no operational leverage
MEDIUM42% revenue growth, −0.7% PAT growth. Deep value-chain promised margin expansion, delivered WC inflation. Risk: further scale without profitability growth erodes return on capital.
The Bull-Bear Ledger
BULL: 42% revenue growth is real, driven by volume + raw-material price inflation; capacity utilization 95–97% justifies expansion to 200 MT.
BULL: Direct African sourcing and FSSC 22,000 certification are strategic moats; long-term vision (1,000 MT by FY37) is credible.
BULL: Promoter-heavy ownership (63.74%) suggests insider confidence in the turnaround strategy.
BEAR: Profitability flat (−0.7% PAT) despite 42% revenue growth; zero operational leverage, execution risk on capex.
BEAR: Finance costs (₹8.39 Cr) consume 97% of PAT; leverage is the binding constraint, not operations.
BEAR: Management evasive on guidance and margin improvement; defensive on analyst scrutiny; capex timelines slipping.
BEAR: Margin improvement entirely commodity-price-dependent, not operational excellence; uncontrollable outcome.
The Debate
What to Watch Next
1 · CNSL oil & solar commissioning (December 2026 target, already delayed)
The first tangible test of whether capex unlocks new margin sources. Management has not quantified expected revenue or EBITDA from CNSL, only promised 'positive impact on H2.' Listen for: (a) actual commissioning date, (b) ramp-in timeline, (c) near-term margin contribution. If delayed further or unquantified, execution credibility collapses.
2 · Raw cashew price direction in H2 FY27
The margin recovery case hinges entirely on commodity deflation. If raw cashew prices stay at ₹200/kilo or rise further, PAT will compress or turn negative. Management explicit: −50% price move = ±50% PAT impact. Track global supply, India sourcing, and auction prices monthly.
3 · Capex timeline adherence (30-month plan, already 2–3 months behind)
The expansion from 140 MT → 200 MT is core to organic growth post-FY28. Further delays beyond the Nov 2026–Sept 2029 window signal execution risk and compound debt service burden. Expect management to provide monthly progress updates; slippage >3 months is a red flag.
4 · Q3 FY27 PAT delivered — the post-CNSL read on leverage-adjusted growth
If Q3 PAT shows organic growth (ex commodity inflation), the expansion thesis gains credibility. If Q3 PAT remains flat or negative, the debt burden is unsustainable and a capex write-down or equity raise becomes likely.
The Honest Close
Aelea Commodities delivered strong revenue growth this quarter, but the profit line reveals a company in structural transition — and not winning yet. Debt has doubled, working capital has ballooned, and finance costs now consume 97% of profit. The company is banking on capex (CNSL, solar, expansion) and commodity deflation to unlock margin recovery, but management has not quantified the path and is already slipping on timelines.
The market has priced this in: the stock is down 68% from its all-time high and deep in oversold territory. Promoter ownership is high, but institutional interest is minimal — a signal that even patient capital is unconvinced.
This is a hold, not a buy. Until CNSL/solar delivers on a quantified timeline and capex expansion converts to PAT growth (not just revenue), the stock remains leveraged to commodity prices and execution risk. The single number to track from here is Q3 FY27 PAT — if it remains flat or negative, the expansion thesis is in jeopardy.
Aelea H1 FY27: revenue up 42% YoY but consolidated PAT flat as finance costs surge 5x
PAT -0.77% YoY · revenue +41.95% · margins compressing
₹246.74 Cr
+41.95% YoY
₹8.64 Cr
-0.77% YoY
3.5%
-1.5pp YoY
₹4.24
Aelea Commodities' consolidated results for the half year ended September 30, 2026 (the company reports semi-annually, not quarterly, as an SME listing) show revenue from operations of ₹246.74 Cr, up 41.9% year-on-year from ₹173.83 Cr in H1 FY26. Profit after tax, however, was essentially flat at ₹8.64 Cr versus ₹8.70 Cr a year ago (-0.8% YoY) — a sharp stall in bottom-line growth against the 42% topline expansion, and a marked deceleration from FY26's full-year pace (revenue +109% YoY, EBITDA +366% YoY, per the company's own FY26 disclosures). Standalone PAT was ₹8.95 Cr; the ~3.5% gap to the consolidated figure is explained by a ₹0.31 Cr net loss at one subsidiary flagged separately by the auditors. No exceptional items appear in either period, so the comparison is like-for-like.
Q2 FY-2027 vs prior quarters
The driver is financing cost, not operations. Consolidated net margin compressed to about 3.5% from roughly 5.0% a year ago, even though underlying operating profit (PBT + finance cost + depreciation, excluding other income) actually grew — the squeeze sits entirely below the operating line. Finance costs jumped 5.1x YoY to ₹8.39 Cr from ₹1.64 Cr, as short-term borrowings more than doubled to ₹229.78 Cr (from ₹107.51 Cr at FY26-end) to fund a near-doubling of inventory to ₹214.76 Cr (from ₹110.83 Cr) — consistent with the cashew-processing working-capital cycle, but a real drag on profit this half.
The stock went into the print at ₹140, down 4.5% over the past month of trading.
Management provided guidance indicating a continuation of strong growth rates similar to FY26 into FY27, with significant expansion plans focused on deepening the value chain for cashews and entering new segments like food, feed, fuel, and fertility. While specific numbers for FY28 are not yet available due to strategi
— This quarter: missed
No analyst consensus could be found for this SME-listed microcap (a web search for Q2/H1 FY27 previews turned up none), so vsStreet is unknown. Against management's own framing — the May 2026 concall guided to 'continuation of strong growth rates similar to FY26' — the 42% revenue growth is directionally consistent but well below FY26's 109%, and profit growth has stalled entirely, so this half reads as a miss on the guided trajectory rather than a confirmation of it. No press release specific to this result has been issued yet. Sequentially, using the filing's own H2 FY26 column as the nearest comparable half (true quarterly figures don't exist), revenue rose 18.7% but PAT fell 31.5% — the FY26 second-half profit base (₹12.61 Cr) was unusually strong, so the comparison cuts the other way at the half-year level. The board also used this meeting to approve a new independent director (Bhupeshkumar Parikh, ex-SUMUL Dairy/AMUL General Manager) and accept the resignation of director Chandresh Unagar, alongside approving unspecified 'Business Expansion and Capex.'
W1
Whether finance costs ease in H2 FY27 — short-term borrowings (₹229.78 Cr) now exceed inventory (₹214.76 Cr); a reversal would restore NPM toward the ~5% seen a year ago.
W2
Phase 2 CNSL extraction facility, guided (May 2026 concall) for H2 of this fiscal year with an additional EBITDA margin contribution — needs to show up in the next half's numbers.
W3
Governance follow-through on the two director changes approved this board meeting (new independent director appointment, one resignation accepted).